Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

BACKGROUND: Steroid receptor coactivator 3 (SRC3) is an important coactivator of a number of transcription factors and is associated with a poor outcome in numerous tumours. Steroid receptor coactivator 3 is amplified in 25% of epithelial ovarian cancers (EOCs) and its expression is higher in EOCs c...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmieri, C, Gojis, O, Rudraraju, B, Stamp-Vincent, C, Wilson, D, Langdon, S, Gourley, C, Faratian, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670494/
https://www.ncbi.nlm.nih.gov/pubmed/23652306
http://dx.doi.org/10.1038/bjc.2013.199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670494/
https://www.ncbi.nlm.nih.gov/pubmed/23652306
http://dx.doi.org/10.1038/bjc.2013.199

Ejemplares similares